Drug profile

The FDA adverse-event record for Unspecified Nsaid

22 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Unspecified Nsaid. Species, reactions, and outcomes follow.

#1723 of 2,679
by report volume (all drugs)
22
adverse-event reports
13.6%
death-coded share
Dog
most-reported species
Verify with FDA CVM →

Corpus placement

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Unspecified Nsaid ranks #1671 of 2679 by total reports (22). Death-coded-share rank requires at least 50 reports. National dual: Milbemycin Oxime + Spinosad is #1 of 2679 drugs by total adverse-event reports (149,624) at death-coded-share rank 965 of 1130 drugs with at least 50 reports (2.3%); separately, Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) is #1 highest death-coded share at 97.8% (report rank #821).

149,624
Milbemycin Oxime + Spinosad reports (#1)
97.8%
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) death share (#1)
#1671
This drug, reports of 2679

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Unspecified Nsaid has 22 reports now versus 21 in that prior snapshot: 1 more (4.8%).

Report change
+1
Death-coded reports
+0
Death-coded share
−0.6 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Unspecified Nsaid changes

Signature read: report volume at 22 is the most distinctive stamp on Unspecified Nsaid's FDA AER row.

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
22
Total Reports
3
Deaths Reported
13.6%
Death-coded share of reports

Active Ingredients

Unspecified Nsaid

Administration Routes

UnknownOral

Species Affected

Dog 19
Horse 2
Cat 1

Most Affected Breeds

Retriever - Labrador 3
Beagle 2
Shepherd Dog - German 2
Dachshund - Miniature 1
Corgi - Welsh Cardigan 1
Shih Tzu 1
Horse (unknown) 1
Friesian 1
Pointer (unspecified) 1
Dog (other) 1

Most Reported Reactions

Lethargy (see also Central nervous system depression in Neurological) 6
Diarrhoea 4
Lethargy (see also Central nervous system depression in 'Neurological') 4
Anorexia 4
Hind limb paresis 3
Vomiting 3
Death by euthanasia 3
Reluctant to move 2
Panting 2
General illness 2
Skin lesion NOS 2
Localised hair loss 2

Outcome Breakdown

Outcome Unknown
8 (36.4%)
Ongoing
6 (27.3%)
Recovered/Normal
5 (22.7%)
Euthanized
3 (13.6%)

Unspecified Nsaid Adverse Event Insights

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

What to do with this drug

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Unspecified Nsaid (#1723 of 2,679 by report volume); death-coded 13.6%. PlainBreed drug row · report volume stamp 22 · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →